TRANSIENT REVERSION OF RAS ONCOGENE-INDUCED CELL-TRANSFORMATION BY ANTIBODIES SPECIFIC FOR AMINO-ACID 12 OF RAS PROTEIN
TRANSIENT REVERSION OF RAS ONCOGENE-INDUCED CELL-TRANSFORMATION BY ANTIBODIES SPECIFIC FOR AMINO-ACID 12 OF RAS PROTEIN
复制标题
DOI:
10.1038/314639a0
复制
发表时间:
1985-01-01
期刊:
影响因子:
64.8
通讯作者:
MCCORMICK, F
中科院分区:
文献类型:
--
作者:
FERAMISCO, JR;CLARK, R;MCCORMICK, F
The proteins encoded by therasoncogene are thought to trigger expression of the transformed phenotype in some types of cancer cells. In human cells, therasprotein family consists of several members including normal (proto-oncogene) and mutant (oncogene) forms1–3. In general, the proto-oncogene forms are thought to be involved in the normal growth control of cells, while the mutant forms (which apparently result from somatic mutation of the normalrasgenes) appear to be responsible, in part, for the loss of normal growth control. On microinjection into living normal cells, the purifiedrasoncogene protein (p21) induces a characteristic loss of growth control in cells within several hours4,5. The mutant forms of the differentrasproteins typically contain a single amino-acid change, usually at position 12 or less frequently at position 61 (ref. 6). Here we report that microinjection of antibodies specific for amino acid 12 of the oncogenic v-Ki-rasprotein into cells transformed by this protein causes a transient reversion of the cells to a normal phenotype. The fact that this antibody inhibits binding of GTP to the v-Ki-rasprotein supports the notion that GTP binding is essential to the transforming function of this oncogene product.